Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.

Cyclin D1 is involved in normal regulation of the cell cycle and plays an important role in the transition from G1 to S phase of the cell cycle. The CCND1 gene has a G-->A polymorphism in exon 4 that increases the frequency of alternate splicing. We analyzed the potential role of CCND1 gene polymorphisms in lung cancer patients (n = 151) and in a matched control population (n = 151). DNA was isolated from blood samples, and exon 4 of CCND1 was amplified by polymerase chain reaction. After digestion with MspI, common CCND1 polymorphic alleles were analyzed by means of agarose gel electrophoresis. The data obtained were analyzed using multiple logistic regression. After adjustment for age, sex, and smoking status, the AG genotype was associated with an increased risk for overall lung cancer (odds ratio OR = 1.7, 95% confidence interval CI = 0.92-3.14). No association was found between AA genotype and risk of lung cancer. In smokers, the combined AG+AA genotypes of CCND1 were found to be significant (OR = 1.9, 95% CI = 1.03-3.71, P = 0.03). No positive association was found between CCND1 genotypes in nonsmokers. The results suggest that the CCND1 A870G gene polymorphisms may increase the risk of lung cancer in smokers from north India.

[1]  W. Ryder,et al.  Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. , 1996, British Journal of Cancer.

[2]  P. Peltomäki,et al.  CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. , 2001, Cancer research.

[3]  N Thatcher,et al.  Alternate splicing produces a novel cyclin D1 transcript. , 1995, Oncogene.

[4]  A. Marchetti,et al.  Cyclin D1 and retinoblastoma susceptibility gene alterations in non‐small cell lung cancer , 1998, International journal of cancer.

[5]  M. Spitz,et al.  Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. , 2001, Carcinogenesis.

[6]  Chien-Jen Chen,et al.  Polymorphisms in cyclin D1 gene and hepatocellular carcinoma , 2002, Molecular carcinogenesis.

[7]  L. Le Marchand,et al.  Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. , 2003, JAMA.

[8]  J. Rastad,et al.  The NciI polymorphism in the cyclin D1 gene and sporadic primary hyperparathyroidism , 2001, Journal of internal medicine.

[9]  J. Fujita,et al.  Expression of cyclin E and cyclin D1 in non-small cell lung cancers. , 2001, Lung cancer.

[10]  A. Grossman,et al.  Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. , 2001, Carcinogenesis.

[11]  K. Nagashima,et al.  Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II. , 2001, Lung cancer.

[12]  H. Moch,et al.  Tissue microarrays for gene amplification surveys in many different tumor types. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  J. Siegfried,et al.  Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero‐digestive tract , 2005, Molecular carcinogenesis.

[14]  J. Fraumeni,et al.  Lung cancer and smoking in Shanghai. , 1988, International journal of epidemiology.

[15]  H. McLeod,et al.  Distinct differences in a cyclin D1 single nucleotide polymorphism between ethnic groups , 2001 .

[16]  K. Branigan,et al.  Prognostic significance of cyclin D1 gene (CCND1) polymorphism in epithelial ovarian cancer. , 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[17]  P. Hasleton,et al.  Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. , 1997, British Journal of Cancer.

[18]  R. Catarino,et al.  Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism. , 2005, Cancer genetics and cytogenetics.

[19]  D. Shin,et al.  Cyclin D1 protein expression in lung cancer. , 1996, Yonsei medical journal.

[20]  F. Khuri,et al.  Emerging therapies in non-small-cell lung cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  C. Amos,et al.  Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. , 2000, Cancer research.

[22]  Alan D. Lopez,et al.  Mortality from tobacco in developed countries: indirect estimation from national vital statistics , 1992, The Lancet.

[23]  K. Branigan,et al.  Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  Seiichi Nakamura,et al.  Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population , 2006, Journal of Cancer Research and Clinical Oncology.

[25]  M. Volm,et al.  Association of cyclin D1 expression in lung cancer and the smoking habits of patients. , 1999, Cancer letters.

[26]  R. Houlston,et al.  Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer , 2002, Oncogene.

[27]  T. Habuchi,et al.  Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. , 2002, Carcinogenesis.

[28]  Shi Qiuling,et al.  Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. , 2003, Carcinogenesis.

[29]  C. Matthias,et al.  Cyclin D1, glutathione S-transferase, and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  R. Chetty,et al.  Cyclin D1 and human neoplasia. , 1998, Molecular pathology : MP.

[31]  M. Caputi,et al.  Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis. , 1997, European journal of histochemistry : EJH.